Comments on: Payback: Novartis To Slash Investment In India http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/ News, Comment and Conversation Fri, 10 Feb 2012 22:38:51 +0000 http://wordpress.org/?v=2.6.2 By: Just wait. http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/#comment-19010 Just wait. Tue, 11 Sep 2007 20:50:48 +0000 http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/#comment-19010 If Novartis is miffed at India's copy of Imatinib (Gleevec) just wait until the Chinese knockoff shows up. This is a classic case of shooting one's self in the foot. India has some of the world's best and least expensive organic chemists. Most of the world's API's are synthesized in and exported from India. Regards,, Rxman If Novartis is miffed at India’s copy of Imatinib (Gleevec)
just wait until the Chinese knockoff shows up.
This is a classic case of shooting one’s self in the foot.
India has some of the world’s best and least expensive
organic chemists. Most of the world’s API’s are synthesized
in and exported from India.

Regards,, Rxman

]]> By: Slightly outside the box http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/#comment-17494 Slightly outside the box Wed, 22 Aug 2007 17:21:38 +0000 http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/#comment-17494 I agree that you can't blame Novartis, but do they really think that the situation is that much better in China where IP infringement is rife - along with huge issues of QC and corruption? I'm coming to the conclusion that there is no good place in which to place these kinds of investments if the expectation is that the local market will operate like G8. I think the gain/pain ratio is likely to be negative for a good time to come. I agree that you can’t blame Novartis, but do they really think that the situation is that much better in China where IP infringement is rife - along with huge issues of QC and corruption? I’m coming to the conclusion that there is no good place in which to place these kinds of investments if the expectation is that the local market will operate like G8. I think the gain/pain ratio is likely to be negative for a good time to come.

]]> By: Steve Woodruff http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/#comment-17491 Steve Woodruff Wed, 22 Aug 2007 16:44:54 +0000 http://www.pharmalot.com/2007/08/payback-novartis-to-slash-investment-in-india/#comment-17491 I can't say I blame Novartis for this move. When countries show themselves to have a (hostile/dubious/unfavorable/questionable) posture toward intellectual property concerns, they'd better weigh very carefully the short-term gain/long-term pain ratio. Corporations are free to invest wherever they feel the climate will be best for success - one of the best global checks/balances schemes ever. I can’t say I blame Novartis for this move. When countries show themselves to have a (hostile/dubious/unfavorable/questionable) posture toward intellectual property concerns, they’d better weigh very carefully the short-term gain/long-term pain ratio. Corporations are free to invest wherever they feel the climate will be best for success - one of the best global checks/balances schemes ever.

]]>